FDA Roundup: November 15, 2024
FDA Roundup: November 15, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-15-2024
FDA Roundup: November 15, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-15-2024
FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-aromatic-l-amino-acid-decarboxylase-deficiency
FDA Roundup: November 8, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-8-2024
FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review
http://www.fda.gov/news-events/press-announcements/fda-proposes-ending-use-oral-phenylephrine-otc-monograph-nasal-decongestant-active-ingredient-after
FDA Roundup: November 5, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-5-2024
FDA Roundup: November 1, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-1-2024